Marinus Pharmaceuticals
A biopharmaceutical company developing ganaxolone for the treatment of drug-resistant seizures and neuropsychiatric disorders
2
Funding Rounds
$41.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| El** Ez****** | - | - | |
| Ni**** Vi***** | - | - | - |
| Sc*** Br******** | - | - | |
| Se** H.** Fi***** | - | - | |
| Sa****** Ar**** | - | - | |
| Ti* M. Ma****** | - | - | |
| Sa** No**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Marinus Pharmaceuticals has raised a total of $41m in funding over 2 rounds.
Key Insights:
- Marinus Pharmaceuticals Series C round: $21m
- Marinus Pharmaceuticals Series B round: $20m
Marinus Pharmaceuticals Series C round
$21m
Marinus Pharmaceuticals Series B round
$20m
Industries
Marinus Pharmaceuticals is active in the following industries:
- Engineering
- Biology
- Biomedical engineering
- Technology
- Biotechnology